Answers are grounded in this paper and cite their sources.
The journal Clinical Chemistry has played a major role in facilitating the progress that has occurred in lipid and lipoprotein testing over the past 50 years. In celebration of the 50th anniversary of the Journal, this Special Report highlights five selected topics of highly significant accom-plishments during the past 50 years contributed by key researchers, some whose careers have spanned the entire history of modern lipid analysis and research. An overview of the history of lipid analysis from nonspecific strong acid methods to modern enzymatic assays, fully integrated lipoprotein methods, and the remarkable instrumentation developed by industry is presented by G. Russell Warnick. Dr. Bill Friedewald, whose name is associated with the widely recognized calculation of LDL-cholesterol (1), will relate the genesis of this important development. His 1972 report in Clinical Chemistry (1) has become the most cited ever in the Journal, with more than 6000 citations. Dr. Richard Havel developed an ultracentrifugal method in 1955 that continues to be the common citation for preparative isolation of the lipoproteins (2). The Lipid Research Clinic (LRC)4 laboratories, in addition to assay-ing for cholesterol and triglycerides, separated VLDL from the bottom layer of LDL and HDL for HDL analyses by ultracentrifugation, following this method. Dr. Havel, who is still active in lipid research, provides his views on the history of the lipoproteins and separation methodol-ogy. Drs. Cooper and Myers present the story of how the CDC and the National Heart Lung and Blood Institute (CDC-NHLBI) Lipid Standardization Program was devel-oped over a period of nearly 50 years. The LRC program also focused attention on the need for standardization of lipid and lipoprotein measurements. Dr. Gerald Cooper of the CDC, one of the co-authors of the standardization article (3), has been a leader in the standardization field for 52 years. The CDC standardization effort, led since 1985 by Dr. Gary Meyers, is extensively involved in national and international programs to standardize li-poprotein and other clinical chemistry methods with
No takes yet. Share an insight, caveat, or question.
Rifai et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: